These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25933709)

  • 21. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC).
    Stephens LC; Haire WD; Tarantolo S; Reed E; Schmit-Pokorny K; Kessinger A; Klein R
    Transfus Sci; 1997 Jun; 18(2):187-93. PubMed ID: 10174683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial for maintaining peripheral intravenous lock in children.
    Mok E; Kwong TK; Chan MF
    Int J Nurs Pract; 2007 Feb; 13(1):33-45. PubMed ID: 17244243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.
    Zhong L; Wang HL; Xu B; Yuan Y; Wang X; Zhang YY; Ji L; Pan ZM; Hu ZS
    Crit Care; 2017 Jan; 21(1):5. PubMed ID: 28063456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of heparin flush on patency of the Groshong catheter: a pilot study.
    Mayo DJ; Horne MK; Summers BL; Pearson DC; Helsabeck CB
    Oncol Nurs Forum; 1996 Oct; 23(9):1401-5. PubMed ID: 8899756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta-analysis.
    Wu XH; Chen LC; Liu GL; Zhang TT; Chen XS
    Int J Nurs Pract; 2021 Apr; 27(2):e12913. PubMed ID: 33484061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
    Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
    JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
    Kulkarni M; Elsner C; Ouellet D; Zeldin R
    Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparinized saline vs normal saline for maintenance of intravenous access in neonates: an evidence-based practice change.
    Cook L; Bellini S; Cusson RM
    Adv Neonatal Care; 2011 Jun; 11(3):208-15. PubMed ID: 21730915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis.
    Kaneko Y; Iwano M; Yoshida H; Kosuge M; Ito S; Narita I; Gejyo F; Suzuki M
    Blood Purif; 2004; 22(5):473-9. PubMed ID: 15523172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
    Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
    J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
    Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
    J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.